Susquehanna International Group, LLP Collegium Pharmaceutical, Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 7,593 shares of COLL stock, worth $224,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,593

Previous 19,300 60.66%

Holding current value

$224,600

Previous $621,000 52.82%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$31.4 - $39.07 $238,420 - $296,658	7,593 New	7,593 $293,000
Q1 2024 May 07, 2024	SELL	$31.23 - $40.91 $660,389 - $865,082	-21,146 Reduced 51.94%	19,566 $759,000
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $664,043 - $966,565	31,382 Added 336.36%	40,712 $1.25 Million
Q3 2023 Nov 14, 2023	SELL	$21.23 - $24.28 $83,157 - $95,104	-3,917 Reduced 29.57%	9,330 $208,000
Q2 2023 Aug 11, 2023	SELL	$21.06 - $24.0 $256,742 - $292,584	-12,191 Reduced 47.92%	13,247 $284,000
Q1 2023 May 16, 2023	BUY	$23.0 - $29.88 $585,074 - $760,087	25,438 New	25,438 $610,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $165,174 - $214,748	10,684 New	10,684 $171,000
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $130,952 - $159,762	7,483 Added 76.87%	17,217 $322,000
Q2 2021 Aug 11, 2021	SELL	$21.74 - $25.28 $1.35 Million - $1.57 Million	-62,072 Reduced 86.44%	9,734 $230,000
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $759,540 - $949,531	42,599 Added 145.85%	71,806 $1.44 Million
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $12,453 - $18,902	-804 Reduced 2.68%	29,207 $511,000
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $214,739 - $393,457	15,460 Added 106.25%	30,011 $490,000
Q3 2019 Nov 14, 2019	SELL	$10.16 - $13.28 $433,110 - $566,113	-42,629 Reduced 74.55%	14,551 $167,000
Q2 2019 Aug 16, 2019	BUY	$10.62 - $16.59 $16,524 - $25,814	1,556 Added 2.8%	57,180 $752,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $240,383 - $375,514	-22,635 Reduced 28.92%	55,624 $731,000
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $430,156 - $558,472	19,741 Added 33.73%	78,259 $1.87 Million
Q1 2018 May 15, 2018	SELL	$18.15 - $29.21 $151,715 - $244,166	-8,359 Reduced 12.5%	58,518 $1.5 Million
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $385,150 - $792,663	41,414 Added 162.64%	66,877 $1.24 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $232,986 - $304,792	25,463	25,463 $267,000

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Collegium Pharmaceutical, Inc Transaction History